Professional Overview
May Orfali is a seasoned medical executive currently serving as the Chief Medical Officer at GEMMA Biotherapeutics, utilizing her expertise in the biotechnology and pharmaceutical industries to drive innovation and growth. Her key expertise areas include rare diseases, oncology, and medical consulting, with a strong focus on developing strategic plans to advance medical research and product development.
Experience Summary
Current Role
As the Chief Medical Officer at GEMMA Biotherapeutics, May is responsible for overseeing the company's medical strategy, leading cross-functional teams, and providing expertise in medical affairs, clinical development, and regulatory compliance. In her current position, she has achieved significant milestones in advancing the company's pipeline and fostering collaborations with key stakeholders.
Career Progression
May's career trajectory is marked by notable roles that demonstrate her growth and expertise in the industry. Previously, she served as the Chief Medical Officer at Harbinger Health, Medical Advisor and CMO Consultant at Bioasis Technologies Inc., and held various leadership positions at Sigilon Therapeutics, Inc., including EVP and CMO, CMO Consultant, and Interim CMO. These roles have equipped her with a deep understanding of the complexities of the biotechnology and pharmaceutical industries.
Areas of Expertise
May's areas of expertise include:
- Industry-specific skills: rare disease and oncology research, medical consulting, and strategic planning
- Technical competencies: clinical development, regulatory compliance, and medical affairs
- Leadership and management capabilities: cross-functional team leadership, collaboration, and communication
Professional Impact
Throughout her career, May has contributed to numerous projects and initiatives that have positively impacted the biotechnology and pharmaceutical industries. Her work has focused on advancing medical research, developing innovative treatments, and improving patient outcomes.
Conclusion
May Orfali's professional trajectory is characterized by her commitment to advancing medical research and innovation in the biotechnology and pharmaceutical industries. Currently, she is focused on driving growth and development at GEMMA Biotherapeutics, leveraging her expertise and experience to make a meaningful impact. As a seasoned medical executive, May offers a unique value proposition, combining strategic vision, technical expertise, and leadership capabilities to deliver results-driven solutions.
